CD79A and nasopharyngeal carcinoma: The primary objective of this study is to investigate the diagnostic potential utility of P85-Ab, both independently and when combined with VCA-IgA, Rta-IgG, and Zta-IgA antibodies, in the context of nasopharyngeal carcinoma.